Global Blood Therapeutics, Inc. Increase (Decrease) in Other Current Liabilities
Global Blood Therapeutics, Inc. reported Increase (Decrease) in Other Current Liabilities of -$12.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-23.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2022-02-23
- Global Blood Therapeutics, Inc. increase (decrease) in other current liabilities for the quarter ending 2021-12-31 was -$12.00K, a 118.75% decline year-over-year.
- Global Blood Therapeutics, Inc. increase (decrease) in other current liabilities for the quarter ending 2020-12-31 was $64.00K.
- Global Blood Therapeutics, Inc. increase (decrease) in other current liabilities for the quarter ending 2020-09-30 was -$807.00K.
- Global Blood Therapeutics, Inc. increase (decrease) in other current liabilities for the quarter ending 2019-12-31 was -$1.45M.
- Global Blood Therapeutics, Inc. increase (decrease) in other current liabilities for fiscal 2021 was -$12.00K.
- Global Blood Therapeutics, Inc. increase (decrease) in other current liabilities for fiscal 2020 was -$587.00K.
- Global Blood Therapeutics, Inc. increase (decrease) in other current liabilities for fiscal 2019 was -$1.48M, a 299.73% decline from fiscal 2018.
- Global Blood Therapeutics, Inc. increase (decrease) in other current liabilities for fiscal 2018 was $742.00K.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 6 month | Increase (Decrease) in Other Current Liabilities 9 month | Increase (Decrease) in Other Current Liabilities 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | -$12.00K 10-K · filed 2022-02-23 | ||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-04 | |||
| 2020-12-31 | $64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | -$743.00K derived: sum of 2 quarters · filed 2022-02-23 | -$587.00K 10-K · filed 2022-02-23 | |
| 2020-09-30 | -$807.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$651.00K 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $156.00K 10-Q · filed 2020-08-05 | |||
| 2019-12-31 | -$1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | -$1.48M 10-K · filed 2022-02-23 | ||
| 2019-09-30 | -$30.00K 10-Q · filed 2020-11-05 | |||
| 2018-12-31 | $742.00K 10-K · filed 2021-02-24 | |||
| 2017-12-31 | -$63.00K 10-K · filed 2020-02-26 | |||
| 2016-12-31 | $23.00K 10-K · filed 2019-02-27 | |||
| 2015-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $15.00K derived: sum of 2 quarters · filed 2018-02-27 | $19.00K 10-K · filed 2018-02-27 | |
| 2015-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$7.00K 10-Q · filed 2015-11-12 | ||
| 2015-06-30 | $4.00K 10-Q · filed 2015-09-24 | |||
| 2014-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $9.00K derived: sum of 2 quarters · filed 2017-03-13 | $17.00K 10-K · filed 2017-03-13 | |
| 2014-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$2.00K 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $8.00K 10-Q · filed 2015-09-24 | |||
| 2013-12-31 | $38.00K 10-K · filed 2016-03-29 |